We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+33.7%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$448M
AUM Growth
+$66.9M
Cap. Flow
-$28.8M
Cap. Flow %
-6.42%
Top 10 Hldgs %
42.48%
Holding
111
New
29
Increased
18
Reduced
19
Closed
41

Top Sells

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$23.9M
2
MSTR icon
Strategy Inc
MSTR
+$17.2M
3
META icon
Meta Platforms (Facebook)
META
+$11.5M
4
ADEA icon
Adeia
ADEA
+$10.1M
5
BCO icon
Brink's
BCO
+$9.96M

Sector Composition

Rank Sector Weight
1 Technology 29.94%
2 Consumer Discretionary 14.37%
3 Communication Services 13.65%
4 Consumer Staples 11.24%
5 Industrials 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMP
51
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.31M 0.52%
54,443
+7,886
+17% +$315K
VSH icon
52
Vishay Intertechnology
VSH
$4.6B
$2.28M 0.51%
+109,971
New +$2.03M
VNT icon
53
Vontier
VNT
$4.54B
$2.27M 0.51%
+67,935
New +$2.1M
BIIB icon
54
CALL
Biogen
BIIB
$30.9B
$2.2M 0.49%
+9,000
New +$2.32M
MD icon
55
Pediatrix Medical
MD
$2.2B
$2.2M 0.49%
89,721
-1,272,670
-93% -$23.9M
FMX icon
56
Fomento Económico Mexicano
FMX
$41.2B
$2.2M 0.49%
29,036
-38,824
-57% -$2.6M
CONXU
57
DELISTED
CONX Corp. Unit
CONXU
$2.09M 0.47%
+200,000
New +$2.03M
CHNG
58
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$1.93M 0.43%
103,553
-397,460
-79% -$6.53M
RCEL icon
59
Avita Medical
RCEL
$137M
$1.69M 0.38%
+90,706
New +$1.99M
SAH icon
60
Sonic Automotive
SAH
$3.56B
$1.61M 0.36%
+41,777
New +$1.7M
GRA
61
DELISTED
W.R. Grace & Co.
GRA
$1.57M 0.35%
+28,572
New +$1.44M
SMC
62
Summit Midstream
SMC
$420M
$1.54M 0.34%
+123,643
New +$1.59M
LGF.B
63
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$1.54M 0.34%
+148,637
New +$1.23M
LAB icon
64
Standard BioTools
LAB
$342M
$1.4M 0.31%
232,595
-74,234
-24% -$488K
CCMP
65
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$605K 0.13%
+4,000
New +$599K
NVT icon
66
nVent Electric
NVT
$21.6B
$559K 0.12%
+24,016
New +$506K
KLR
67
DELISTED
Kaleyra, Inc.
KLR
$325K 0.07%
9,413
CCO icon
68
Clear Channel Outdoor Holdings
CCO
$1.22B
$277K 0.06%
167,581
+13,000
+8% +$16.4K
CANO
69
DELISTED
Cano Health, Inc.
CANO
$213K 0.05%
+159
New +$182K
ATCX
70
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$123K 0.03%
+17,438
New +$124K
AAP icon
71
Advance Auto Parts
AAP
$3.53B
-16,480
Closed -$2.53M
ACM icon
72
Aecom
ACM
$9.46B
-8,520
Closed -$356K
ARMK icon
73
Aramark
ARMK
$15B
-252,726
Closed -$4.83M
OPTU
74
Optimum Communications Inc
OPTU
$298M
-93,201
Closed -$2.42M
BABA icon
75
Alibaba
BABA
$276B
-855
Closed -$251K

Similar funds

Clearline Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Clearline Capital held 111 positions worth $448M, up 18% from $381M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Clearline Capital withdrew a net $28.8M in Q4 2020, closing 41 positions and reducing 19 holdings. Its most notable exit was Strategy Inc, an estimated $17.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Clearline Capital opened a new position in Expedia Group worth $14.4M.

  • Clearline Capital's largest Q4 2020 buy was Expedia Group: 108,789 shares worth $14.4M.
  • Clearline Capital added most to John Wiley & Sons Class A in Q4 2020, an estimated $8.51M increase.
  • Clearline Capital's biggest Q4 2020 reduction was Pediatrix Medical, cutting an estimated $23.9M.
  • Clearline Capital fully exited Strategy Inc in Q4 2020, selling an estimated $17.2M.
  • Clearline Capital's ten largest holdings make up 42% of its $448M portfolio in Q4 2020.
  • Clearline Capital opened 29 new positions and closed 41 in Q4 2020.
  • Clearline Capital's portfolio value rose 18% quarter-over-quarter to $448M.

Based on Clearline Capital's 13F filing for Q4 2020, filed 16 Feb 2021.